Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 28, 2013
Sep. 29, 2012
Operating activities    
Net loss $ (14,309) $ (5,195)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 9,736 11,533
Amortization of intangible assets 299 1,012
Impairment loss on property and equipment 4,832 0
Impairment loss on intangible assets 1,245 0
Deferred income taxes 109 374
Share-based compensation expense 1,065 1,408
Stock awards issued for non-employee director service 31 43
Amortization of deferred financing costs 61 69
Loss on debt extinguishment   360
(Gain) loss from disposition of assets (39) 4
Changes in operating assets and liabilities:    
Accounts receivable 2,536 (661)
Inventory 2,550 3,588
Other current assets 475 (881)
Other non-current assets 142  
Accounts payable and accrued expenses (10,303) (12,138)
Other current liabilities (864) (3,659)
Other non-current liabilities 515 446
Net cash used in operating activities (1,919) (3,697)
Investing activities    
Additions to property and equipment (6,679) (7,853)
Proceeds from sale of property and equipment 42 14
Cash paid for intangible assets   (16)
Proceeds from sale of marketable securities and investments   3,171
Purchases of marketable securities and investments (4) (8)
Purchases of company-owned life insurance (106) (166)
Net cash used in investing activities (6,747) (4,858)
Financing activities    
Borrowings from revolving loan payable 16,667 23,061
Payments made on revolving loan payable (24,590) (5,935)
Proceeds from sale leaseback transaction 9,584  
Payments made on long-term debt   (17,875)
Payment of debt extinguishment costs   (175)
Payments of debt financing costs   (359)
Payments on capital leases (126) (104)
Proceeds from exercise of stock options 22 663
Net cash provided by (used in) financing activities 8,739 (724)
Effect of exchange rate changes on cash (4) 20
Net change in cash and cash equivalents 69 (9,259)
Cash and cash equivalents, beginning of period 1,030 10,335
Cash and cash equivalents, end of period 1,099 1,076
Supplemental disclosure of non-cash investing and financing activities:    
Accrued asset purchases 848 2,164
Property acquired under capital lease 322 104
Unrealized gain on investments 4 30
Supplemental disclosure of cash flow information:    
Cash received (paid) during the period for income taxes 32 (17)
Cash paid during the period for interest (628) (293)
Common Stock [Member]
    
Financing activities    
Proceeds from issuance of common stock 2,235  
Payment of issuance costs (223)  
Series A Convertible Preferred Stock [Member]
    
Financing activities    
Proceeds from issuance of Series A convertible preferred stock 6,017  
Payment of issuance costs $ (847)